Letter to the Editor RE: Schwartz, Editorial Comment on: The Impact of Ureteral Deformation and External Ureteral Pressure on Stent Failure in Extrinsic Ureteral Obstruction--An In Vitro Experimental Study by Shilo et al. (From: Shilo Y, Modai J, Leibovici D, et al. J Endourol 2019;34:74; DOI: 10.1089/end.2019.0636).

Autor: Shilo Y; Department of Urology, Kaplan Medical Center, Rehovot, Israel., Modai J; Department of Urology, Kaplan Medical Center, Rehovot, Israel., Leibovici D; Department of Urology, Kaplan Medical Center, Rehovot, Israel., Dror I; Department of Earth and Planetary Sciences, Weizmann Institute of Science, Rehovot, Israel., Berkowitz B; Department of Earth and Planetary Sciences, Weizmann Institute of Science, Rehovot, Israel.

Publikováno v: Journal of endourology [J Endourol] 2020 Jan; Vol. 34 (1), pp. 75. Date of Electronic Publication: 2020 Jan 02.

Organ preservation for muscle-invasive bladder cancer by transurethral resection: Leibovici D, Kassouf W, Pisters LL, Pettaway CA, Wu X, Dinney CP, Grossman HB, Department of Urology, University of Texas, M.D. Anderson Cancer Center, Houston, TX.

Autor: See, William A.

Publikováno v: In Urologic Oncology: Seminars and Original Investigations 2008 26(3):334-334

Letter to the Editor RE: Schwartz, Editorial Comment on: The Impact of Ureteral Deformation and External Ureteral Pressure on Stent Failure in Extrinsic Ureteral Obstruction––An In Vitro Experimental Study by Shilo et al. (From: Shilo Y, Modai J, Leibovici D, et al. J Endourol 2020;34:74; DOI: 10.1089/end.2019.0636)

Autor: Ishai Dror, Dan Leibovici, Brian Berkowitz, Yaniv Shilo, Jonathan Modai

Publikováno v: Journal of Endourology. 34:75-75

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::969cae5edec394ceb318dfcc5dee69a9
https://doi.org/10.1089/end.2020.29073.ysh

Drainage of infected kidneys with ureteral stents: does size matter?

Autor: Modai J; Department of Urology, Kaplan Medical Center, Affiliated With the Hebrew University, 7661041, Rehovot, Israel., Shilo Y; Department of Urology, Kaplan Medical Center, Affiliated With the Hebrew University, 7661041, Rehovot, Israel., Leibovici D; Department of Urology, Kaplan Medical Center, Affiliated With the Hebrew University, 7661041, Rehovot, Israel., Dror I; Department of Earth and Planetary Sciences, Weizmann Institute of Science, 7610001, Rehovot, Israel., Kalchenko V; Department of Veterinary Resources, Weizmann Institute of Science, 7610001, Rehovot, Israel., Berkowitz B; Department of Earth and Planetary Sciences, Weizmann Institute of Science, 7610001, Rehovot, Israel. brian.berkowitz@weizmann.ac.il.

Publikováno v: World journal of urology [World J Urol] 2022 Aug; Vol. 40 (8), pp. 2041-2046. Date of Electronic Publication: 2022 Jun 22.

A clinical evaluation of an ex vivo organ culture system to predict patient response to cancer therapy.

Autor: Golan S; Department of Urology, Beilinson Hospital - Rabin Medical Center, Petah Tikva, Israel., Bar V; Curesponse, Rehovot, Israel., Salpeter SJ; Curesponse, Rehovot, Israel., Neev G; Curesponse, Rehovot, Israel., Creiderman G; Department of Urology, Beilinson Hospital - Rabin Medical Center, Petah Tikva, Israel., Kedar D; Department of Urology, Beilinson Hospital - Rabin Medical Center, Petah Tikva, Israel., Aharon S; Curesponse, Rehovot, Israel., Turovsky L; Curesponse, Rehovot, Israel., Zundelevich A; Curesponse, Rehovot, Israel., Shahar H; Curesponse, Rehovot, Israel., Shapira H; Curesponse, Rehovot, Israel., Mallel G; Curesponse, Rehovot, Israel., Stossel E; Curesponse, Rehovot, Israel., Gavert N; Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot, Israel., Straussman R; Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot, Israel., Dotan Z; Department of Oncology, Sheba Medical Center, Ramat Gan, Israel., Berger R; Department of Oncology, Sheba Medical Center, Ramat Gan, Israel., Stossel C; Department of Oncology, Sheba Medical Center, Ramat Gan, Israel., Golan T; Department of Oncology, Sheba Medical Center, Ramat Gan, Israel., Halperin S; Department of Oncology, Sheba Medical Center, Ramat Gan, Israel., Leibovici D; Department of Urology, Kaplan Medical Center, Rehovot, Israel., Breuer S; Sharett Institute of Oncology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Rottenberg Y; Sharett Institute of Oncology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Applebaum L; Sharett Institute of Oncology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Hubert A; Sharett Institute of Oncology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Nechushtan H; Sharett Institute of Oncology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Peretz T; Sharett Institute of Oncology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Zick A; Sharett Institute of Oncology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Chertin B; Department of Urology, Shaare Zedek Medical Center, Jerusalem, Israel., Koulikov D; Department of Urology, Shaare Zedek Medical Center, Jerusalem, Israel., Sonnenblick A; Department of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Rosenbaum E; Institute of Oncology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel.

Publikováno v: Frontiers in medicine [Front Med (Lausanne)] 2023 Sep 28; Vol. 10, pp. 1221484. Date of Electronic Publication: 2023 Sep 28 (Print Publication: 2023).